Caveolin-1 rs4730751 single-nucleotide polymorphism may not influence kidney transplant allograft survival

Archive ouverte

Maanaoui, Mehdi | Lenain, Remi | Hamroun, Aghiles | van der Hauwaert, Cynthia | Lopez, Benjamin | Gibier, Jean-Baptiste | Frimat, Marie | Savary, Gregoire | Hennart, Benjamin | Larrue, Romain | Pottier, Nicolas | Broly, Franck | Provot, Francois | Hazzan, Marc | Glowacki, Francois | Cauffiez, Christelle

Edité par CCSD ; Nature Publishing Group -

International audience. Caveolin-1 is a protein (encoded by the CAV1 gene) supposedly harboring a protective effect against fibrosis. CAV1 rs4730751 single nucleotide polymorphism (SNP) AA genotype was initially associated with lower graft survival compared to non-AA. However, subsequent studies could not find the same effect. CAV1 rs4730751 SNP was investigated on 918 kidney donors. Multivariate Cox-model analyses were performed to evaluate risk factors for graft loss. Longitudinal changes on long-term estimated glomerular filtration rate (eGFRs) were evaluated with a linear mixed model. Histopathological findings from protocolled biopsies after 3 months post transplantation were also analyzed. Donor CAV1 rs4730751 genotyping proportions were 7.1% for AA, 41.6% for AC and 51.3% for CC. The AA genotype, compared to non-AA, was not associated with lower graft survival censored or not for death (multivariate analysis: HR = 1.23 [0.74-2.05] and HR = 1.27 [0.84-1.92]). Linear mixed model on long-term eGFRs revealed also no significant difference according to the genotype, yet we observed a trend. AA genotype was also not associated with a higher degree of fibrosis index on protocolled kidney biopsies at 3 months. To conclude, donor CAV1 rs4730751 SNP may impact on kidney transplantation outcomes, but this study could not confirm this hypothesis.

Suggestions

Du même auteur

Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective Study

Archive ouverte | Lenain, Rémi | CCSD

International audience. The pharmacokinetic variability of tacrolimus can be partly explained by CYP3A5 activity. Our objective was to evaluate a tacrolimus sparing policy on renal graft outcome according to CYP3A5 ...

Impact du polymorphisme génétique de la caveolin-1 du donneur en transplantation rénale

Archive ouverte | Maanaoui, Mehdi | CCSD

International audience

Association between HOMA2 based beta-cell function or insulin resistance and long-term outcomes in kidney transplant recipients with type 2 diabetes.

Archive ouverte | Maanaoui, Mehdi | CCSD

International audience. Type 2 diabetes (T2D) is a common comorbidity in kidney transplant recipients, representing a significant proportion of the candidate pool. Post-kidney transplantation management of T2D remai...

Chargement des enrichissements...